Improvement or remission of arthritic symptoms was noted in 21 of the 25 volunteers, including all of the JIA patients. As their blood levels of fetal DNA rose, so did their chances of experiencing relief from arthritis. However, by the fourth month after delivery, 90 percent of those who showed improvement experienced a recurrence of arthritis, which coincided with a sharp drop in their blood levels of fetal DNA.
Among the four patients whose pregnancy did not relieve their arthritis, blood levels of fetal DNA were low or absent throughout their pregnancies.
The researchers described their study as the first to examine fetal DNA in pregnant RA patients. They called for larger-scale research to explore whether fetal DNA may have a role in treating inflammatory arthritis.
The study was published last month in Arthritis & Rheumatism.
Copyright 2000-2006 HealthCentersOnline, Inc.